Ascletis Pharma Inc. (ASCLF) has a market capitalization of $2.22B and trades at $2.10. The 52-week range is 0.6217-2.29.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of -7, Earnings Per Share (EPS) of $-0.30, annual revenue of $1.28M.
The stock has a beta of 0.59, operates in the Healthcare sector.